Patents
Patents for C07H 5 - Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium (3,671)
05/1998
05/22/1998WO1998021221A2 1-thiogalactose derivatives
05/22/1998WO1998021220A2 Saccharide derivatives
05/22/1998WO1998021176A1 Novel pseudoceramides, and dermatologic external preparations containing the same
05/22/1998CA2256692A1 Saccharide derivatives
05/22/1998CA2256674A1 1-galactose derivatives
05/22/1998CA2256016A1 1-thiogalactose derivatives
05/06/1998EP0839053A2 Compounds and methods for treatment of egf receptor associated cancers and purification of the egf receptor
05/06/1998EP0839042A1 Bacterial inhibition with an oligosaccharide compound
05/05/1998US5747468 Polydiallyldimethylammonium chloride with saccharides and ethers
04/1998
04/29/1998EP0837869A2 Method for producing synthetic n-linked glycoconjugates
04/29/1998EP0692475A4 N-METHYL-N-/-g(a),-g(D)-GLUCOPYRANOZIL/AMMONIA-2-/ACRIDON-9-ON-10-YL/ACETATE/CYCLOPHERONE, WITH INTERFERON PRODUCING, ANTI-VIRAL (INCLUDING ANTI-HIV), ANTI-PARASITIC, ANTI-PROMOTER AND RADIOPROTECTIVE PROPERTIES
04/28/1998US5744451 N-substituted glutamic acid derivatives with interleukin-1 β converting enzyme inhibitory activity
04/22/1998EP0836609A1 Method and device for synthesising labelled compounds
04/22/1998EP0764027A4 Method for protection against genotoxic mutagenesis
04/22/1998CN1179722A Combination therapy for HIV infection using HIV protease inhibitor indinavir and reverse transcriptase inhibitor 3TC, optionally together with AZT, DDI or DDC
04/22/1998CN1179432A Process for preparing N-alkyl polyhydroxyalkyl amines in aqueous/hydroxy solvents
04/16/1998DE19640791A1 Glycokonjugate als Inhibitoren der viralen Zelladhäsion Glycoconjugates as inhibitors of viral cell adhesion
04/14/1998US5739316 Contacting with an aqueous alkaline solution of a diepoxide
04/09/1998WO1998014458A1 Antiinflammatory cell adhesion inhibitors
04/09/1998WO1998014215A2 Glycoconjugates as virus cell adhesion inhibitors
04/07/1998US5736625 Method for stabilizing proteins with saccharide linked protein polymer conjugates
04/07/1998US5736533 Inhibiting colonization of streptococcus pneumoniae, hemophilus influenza or parainfluenza, burkholderia (pseudomonas) cepacia by administering binding inhibiting oligosaccharide
04/02/1998WO1998013352A1 2-deoxy-2-amino(or 2-methylamino)-d-glucose salts comprising n-arachidonacetic acid and showing anti-microbial activity
04/01/1998EP0832898A2 Substituted amino acid derivatives
04/01/1998EP0831847A2 Use of di-beta-d-glucopyranosylamine compounds for controlling inflammatory reactions, and method of synthesis
03/1998
03/25/1998EP0830137A1 Ionic molecular conjugates of n-acylated derivatives of poly(2-amino-2-deoxy-d-glucose) and polypeptides
03/19/1998WO1998011118A1 Lewis x derivatives
03/12/1998DE19704651A1 Chitin or chitosan material
03/11/1998CN1037682C Process for preparing 2 -hydroxymethyl -5 -(5 -fluorocytosin -1 -yl) -1 ,3 -oxathiolane
03/09/1998CA2214728A1 Substituted amino acid derivatives
03/03/1998US5723504 Amadori reaction compounds and products, process for their manufacture, and their use as cytokine inducers
02/1998
02/26/1998DE19735868A1 Glucosamine sulphate preparation in stable crystalline form
02/25/1998EP0824537A1 Iodine derivatives of monosaccharides useful as radiopharmaceutical products
01/1998
01/14/1998EP0818459A2 Carbohydrate derivatives
01/08/1998WO1998000398A1 Method for the synthesis of amines and amino acids with organoboron derivatives
01/07/1998EP0815127A1 Fucopeptides
01/07/1998EP0598769B1 Process for preparing n-alkyl polyhydroxyalkyl amines in aqueous/hydroxy solvents
01/06/1998US5705713 Preparation of fluoro compounds
12/1997
12/30/1997CA2019675C Cationic polysaccharides and reagents for their preparation
12/18/1997WO1997047208A1 Foods or drinks
12/18/1997WO1997028104A8 Buffer systems for use in stabilizing pharmaceutical preparations
12/04/1997WO1997045436A1 Carbohydrate derivatives and their solid-phase synthesis
12/04/1997CA2255559A1 Carbohydrate derivatives and their solid-phase synthesis
12/02/1997US5693623 Topical preparations for the treatment of acne and acneiform dermatitis
11/1997
11/27/1997DE19621177A1 Kohlenhydratderivate und ihre Synthese an fester Phase Carbohydrate derivatives and their synthesis on solid phase
11/25/1997US5691154 Contacting an antibody polymer conjugate with an antigen to bind antigen
11/19/1997EP0806957A1 Combination therapy for hiv infection using the hiv protease inhibitor indinavir adn the reverse transcriptase inhibitor 3tc, optionally together with azt, ddi or ddc
11/19/1997EP0806935A2 Anti-adhesive active principles
11/13/1997WO1997042203A1 Method and device for synthesising labelled compounds
10/1997
10/29/1997CN1163270A Anti-hyerplasia and anti-inflammatory compound: pentose monosaccharide devivative
10/21/1997US5679655 Method of treating lesions resulting from genital herpes with hyaluronic acid-urea pharmaceutical compositions
10/01/1997EP0798307A1 Fluoro-deoxyglucose synthesizer using columns
09/1997
09/25/1997WO1997034906A1 Sulfinyl hexose derivatives useful for glycosylation
09/25/1997CA2249342A1 Sulfinyl hexose derivatives useful for glycosylation
09/24/1997EP0796101A1 Compositions and methods for inhibiting fungal cell wall formation
09/18/1997WO1997033896A1 Polyvalent polymers for the treatment of rotavirus infection
09/18/1997CA2250319A1 Polyvalent polymers for the treatment of rotavirus infection
09/16/1997US5668272 Method for producing synthetic N-linked glycoconjugates
09/12/1997WO1997028104A3 Buffer systems for use in stabilizing pharmaceutical preparations
09/09/1997US5665702 Ionic molecular conjugates of N-acylated derivatives of poly(2-amino-2-deoxy-D-glucose) and polypeptides
09/02/1997US5663355 Glucosidase enzyme inhibitors
08/1997
08/19/1997US5658886 Acridinone derivative, compositions containing same and a method for using same to treat Chlamydia trachomatis
08/07/1997WO1997028104A2 Buffer systems for use in stabilizing pharmaceutical preparations
08/07/1997DE19648650A1 Buffer solution for stabilising pharmaceutical compositions
08/07/1997CA2244213A1 Buffer systems for stabilizing pharmaceutical preparations
07/1997
07/30/1997EP0668866B1 Anti-proliferative and anti-inflammatory compounds: derivatives of pentose monosaccharides
07/15/1997US5648344 Methods of treating inflammation using selection binding compounds
07/03/1997WO1997023637A1 Galactopyranosides and their use
07/03/1997CA2240941A1 Galactopyranosides and their use
07/02/1997EP0781600A2 Virus-removing filter
06/1997
06/17/1997US5639633 Stabilizing the protein by biochemical conjugation with linker groups
05/1997
05/20/1997US5631245 Di-beta-glycopyranosylamine from glucose and nitrogen base
05/20/1997US5631242 Hyaluronic acid-urea pharmaceutical compositions utilized for treatment of diseases of cutis
05/09/1997CA2235598A1 Novel nucleoside derivatives and process for preparing the same
05/07/1997EP0771815A1 Sulfated and phosphated saccharide derivatives, process for the preparation of the same and use thereof
04/1997
04/29/1997US5625098 Process for preparing N-alkyl polyhydroxyalkyl amines in aqueous/hydroxy solvents
04/29/1997US5624915 Hyaluronic acid-urea pharmaceutical compositions and uses
04/23/1997EP0769498A1 Sulfonamide derivatives with elastase inhibiting activity
04/23/1997EP0769490A1 Reagent for the detection and isolation of carbohydrates or glycan-receptors
04/17/1997WO1997003701A3 Compounds and methods for treatment of egf receptor associated cancers and purification of the egf receptor
04/15/1997US5620902 Sialic acid glycosides, antigens, immunoadsorbents, and methods for their preparation
04/08/1997US5618798 Use of sucralfate to treat baldness
03/1997
03/28/1997CA2186665A1 Sulfonamide derivatives
03/27/1997WO1996039153A3 Use of di-beta-d-glucopyranosylamine compounds for controlling inflammatory reactions, and method of synthesis
03/26/1997EP0764655A1 Cationic unsaturated saccharides, polymers produced from them and their use
03/26/1997EP0764169A2 Drug salts
03/26/1997EP0764027A1 Method for protection against genotoxic mutagenesis
03/25/1997US5614615 Sialyl Lewis X mimetics incorporating fucopeptides
03/20/1997WO1997009981A1 Advanced glycation end-product intermediaries and post-amadori inhibition
03/18/1997US5612476 Anti-endotoxin compounds
03/13/1997WO1997002277A3 Method for producing synthetic n-linked glycoconjugates
03/12/1997CN1034217C Anti-proliferative and anti-inflammatory compounds:derivatives of pentose monosaccharides
03/11/1997US5610039 Oxidizing a glucamine to produce an intermediate compound and reducing intermediate
03/06/1997WO1997008181A1 Solid sucralose
03/06/1997WO1997007809A1 Sulfated disaccharide inhibitors of selectins methods for synthesis and therapeutic use
03/06/1997WO1996023479A3 Anti-adhesive active principles
03/05/1997EP0643069B1 2'-deoxy-2'-fluorocoformycin and stereoisomers thereof
02/1997
02/18/1997US5604206 Complexes containing S(+) phenyl alkane acids and amino sugars
02/12/1997CN1142501A Novel sulphuric acid esters of amino-sugars
02/11/1997US5602262 Process for the preparation of 2-deoxy-2,2-difluoro-β-D-ribo-pentopyranose
1 ... 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37